Related Experiment Video
Updated: May 2, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis
Abstract:
This study aimed to evaluate the impact of high vancomycin serum trough concentrations (≧15 mg/l) on clinical outcomes and nephrotoxicity among adult subjects. We searched MEDLINE, Cochrane Library, and CNKI systematically. A total of 17 studies were included. Meta-analysis found that high trough group showed no significant difference comparing to low trough group in treatment failure [relative risk (RR) 0·91, 95% confidence interval (CI) 0·67-1·24; P = 0·57] and all-cause mortality (RR 1·14, 95% CI 0·81-1·59; P = 0·46). However, the high trough concentrations were associated with lower treatment failure in bacteremia subgroup (RR 0·72, 95% CI 0·59-0·88; P = 0·001). High trough concentrations were associated with an increased risk of vancomycin-induced nephrotoxicity (RR 2·06, 95% CI 1·52-2·79; P<0·00001). Our meta-analysis indicates that high trough concentrations were not significantly superior to low trough concentrations in lowering treatment failure and mortality. Moreover, high trough concentrations significantly increased the risk of nephrotoxicity.
Insights
High vancomycin trough concentrations (≧15 mg/l) did not improve treatment failure or mortality rates. However, these higher levels significantly increased the risk of vancomycin-induced nephrotoxicity in adult patients.
Area of Science:
- Pharmacology
- Clinical Medicine
- Nephrology
Background:
- Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
- Optimizing vancomycin dosing is essential to balance efficacy and toxicity.
- High vancomycin serum trough concentrations are often targeted, but their impact on outcomes requires further evaluation.
Purpose of the Study:
- To evaluate the clinical outcomes and nephrotoxicity associated with high vancomycin serum trough concentrations (≧15 mg/l) in adult patients.
- To compare treatment failure, all-cause mortality, and nephrotoxicity between high and low vancomycin trough concentration groups.
Main Methods:
- Systematic literature search of MEDLINE, Cochrane Library, and CNKI.
- Inclusion of 17 studies for meta-analysis.
- Analysis of clinical outcomes including treatment failure, all-cause mortality, and vancomycin-induced nephrotoxicity.
Main Results:
- No significant difference in overall treatment failure (RR 0.91, P=0.57) or all-cause mortality (RR 1.14, P=0.46) between high and low trough groups.
- A significant reduction in treatment failure was observed in the bacteremia subgroup with high trough concentrations (RR 0.72, P=0.001).
- High vancomycin trough concentrations were significantly associated with an increased risk of nephrotoxicity (RR 2.06, P<0.00001).
Conclusions:
- High vancomycin trough concentrations (≧15 mg/l) are not demonstrably superior to lower concentrations in reducing overall treatment failure or mortality.
- The elevated trough levels significantly elevate the risk of developing vancomycin-induced nephrotoxicity.
- Clinical practice should carefully consider the balance between potential benefits in specific subgroups and the increased risk of kidney injury.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Estimation of k and VD of Aminoglycosides
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Dosage Interval and Administration Route: Determination Methods
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis

